Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-11-000308
Filing Date
2011-04-15
Accepted
2011-04-14 19:35:49
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K appy_10k.htm 10-K 1384780
2 EXHIBIT 10.6.2 ex10x6x2.htm EX-10.6.2 9966
3 EXHIBIT 23 ex23.htm EX-23 4904
4 EXHIBIT 31.1 ex31x1.htm EX-31.1 17023
5 EXHIBIT 31.2 ex31x2.htm EX-31.2 17090
6 EXHIBIT 32 ex32.htm EX-32 11369
7 tablev4.jpg GRAPHIC 38117
  Complete submission text file 0001079973-11-000308.txt   1498848
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 11760778
SIC: 2835 In Vitro & In Vivo Diagnostic Substances